Vasodilators market to reach $8.86 billion by 2030 at 5.5% CAGR, driven by rising prevalence of cardiovascular diseases and sedentary lifestyles.
Read More
Vascular endothelial growth factor inhibitor market to reach $16.23 billion by 2030 at 7.6% CAGR, driven by growing prevalence of cancer and macular degeneration.
Read More
Vaginitis therapeutics market to reach $7.4 billion by 2030 at 11.0% CAGR, driven by increasing prevalence of sexually transmitted diseases among women.
Read More
Vaccine adjuvants market to reach $3.13 billion by 2030 at 9.5% CAGR, driven by growing funding for vaccine research and development activities globally.
Read More
Ursodeoxycholic acid market to reach $1.6 billion by 2030 at 10.7% CAGR, driven by rising prevalence of liver diseases and increasing aging population worldwide.
Read More
Proton pump inhibitors market to reach $4.57 billion by 2030 at 5.6% CAGR, driven by increasing prevalence of gastrointestinal disorders.
Read More
Proteins and amino acids market to reach $63.67 billion by 2030 at 9.0% CAGR, driven by increasing consumption of dietary supplements.
Read More
Protein purification equipment market to reach $8.14 billion by 2030 at 8.0% CAGR, driven by increasing focus on personalized medicine.
Read More
Protein purification and isolation market to reach $17.84 billion by 2030 at 11.5% CAGR, driven by increasing government spending on R&D in pharmaceuticals and biotechnology.
Read More
Protein labeling market to reach $4.89 billion by 2030 at 11.8% CAGR, driven by increased spending on the R&D of proteomics and genomics.
Read More